Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity
Brents, Lisa K, Reichard, Emily E, Zimmerman, Sarah M, Moran, Jeffery H, Fantegrossi, William E, Prather, Paul L
Published in PloS one (06.07.2011)
Published in PloS one (06.07.2011)
Get full text
Journal Article
Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats
Janganati, Venumadhav, Salazar, Paloma, Parks, Brian J, Gorman, Gregory S, Prather, Paul L, Peterson, Eric C, Alund, Alexander W, Moran, Jeffery H, Crooks, Peter A, Brents, Lisa K
Published in Frontiers in pharmacology (09.05.2023)
Published in Frontiers in pharmacology (09.05.2023)
Get full text
Journal Article
481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
Tobacyk, Julia, Parks, Brian J., Coward, Lori, Berquist, Michael D., Gorman, Gregory S., Brents, Lisa K.
Published in Journal of clinical and translational science (01.04.2023)
Published in Journal of clinical and translational science (01.04.2023)
Get full text
Journal Article
Response to article - alternative interpretation of "there is reduced immunohistochemical staining of placental aromatase in severe neonatal opioid withdrawal syndrome"
Tobacyk, Julia, Brents, Lisa K.
Published in The journal of maternal-fetal & neonatal medicine (31.12.2023)
Published in The journal of maternal-fetal & neonatal medicine (31.12.2023)
Get full text
Journal Article
Automated quantification of opioid withdrawal in neonatal rat pups using Ethovision® XT software
Kulbeth, Hanna J., Fukuda, Saki, Brents, Lisa K.
Published in Neurotoxicology and teratology (01.03.2021)
Published in Neurotoxicology and teratology (01.03.2021)
Get full text
Journal Article
Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity
Brents, Lisa K., Gallus-Zawada, Anna, Radominska-Pandya, Anna, Vasiljevik, Tamara, Prisinzano, Thomas E., Fantegrossi, William E., Moran, Jeffery H., Prather, Paul L.
Published in Biochemical pharmacology (01.04.2012)
Published in Biochemical pharmacology (01.04.2012)
Get full text
Journal Article
Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
Tobacyk, Julia, Parks, Brian J., Salazar, Paloma, Coward, Lori U., Berquist, Michael D., Gorman, Gregory S., Brents, Lisa K.
Published in Drug and alcohol dependence (01.08.2023)
Published in Drug and alcohol dependence (01.08.2023)
Get full text
Journal Article
Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands
Chimalakonda, Krishna C, Seely, Kathryn A, Bratton, Stacie M, Brents, Lisa K, Moran, Cindy L, Endres, Gregory W, James, Laura P, Hollenberg, Paul F, Prather, Paul L, Radominska-Pandya, Anna, Moran, Jeffery H
Published in Drug metabolism and disposition (01.11.2012)
Published in Drug metabolism and disposition (01.11.2012)
Get full text
Journal Article
Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors
Rajasekaran, Maheswari, Brents, Lisa K., Franks, Lirit N., Moran, Jeffery H., Prather, Paul L.
Published in Toxicology and applied pharmacology (01.06.2013)
Published in Toxicology and applied pharmacology (01.06.2013)
Get full text
Journal Article
AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies
Seely, Kathryn A., Brents, Lisa K., Franks, Lirit N., Rajasekaran, Maheswari, Zimmerman, Sarah M., Fantegrossi, William E., Prather, Paul L.
Published in Neuropharmacology (01.10.2012)
Published in Neuropharmacology (01.10.2012)
Get full text
Journal Article
Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer
Liu, Xinyi, Jutooru, Indira, Lei, Ping, Kim, KyoungHyun, Lee, Syng-Ook, Brents, Lisa K, Prather, Paul L, Safe, Stephen
Published in Molecular cancer therapeutics (01.07.2012)
Published in Molecular cancer therapeutics (01.07.2012)
Get full text
Journal Article
Differential drug-drug interactions of the synthetic Cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy
Brents, Lisa K, Zimmerman, Sarah M, Saffell, Amanda R, Prather, Paul L, Fantegrossi, William E
Published in The Journal of pharmacology and experimental therapeutics (01.09.2013)
Published in The Journal of pharmacology and experimental therapeutics (01.09.2013)
Get full text
Journal Article
In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
Griffin, Bryce A, Caperton, Caitlin O, Russell, Lauren N, Cabanlong, Christian V, Wilson, Catheryn D, Urquhart, Kyle R, Martins, Bradford S, Zita, Marcelle Dina, Patton, Amy L, Alund, Alexander W, Owens, S Michael, Fantegrossi, William E, Moran, Jeffery H, Brents, Lisa K
Published in The Journal of pharmacology and experimental therapeutics (01.07.2019)
Published in The Journal of pharmacology and experimental therapeutics (01.07.2019)
Get full text
Journal Article
A Major Glucuronidated Metabolite of JWH-018 Is a Neutral Antagonist at CB1 Receptors
Seely, Kathryn A, Brents, Lisa K, Radominska-Pandya, Anna, Endres, Gregory W, Keyes, Gregory S, Moran, Jeffery H, Prather, Paul L
Published in Chemical research in toxicology (16.04.2012)
Published in Chemical research in toxicology (16.04.2012)
Get full text
Journal Article